Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cambrex Facility Completes FDA Inspection | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cambrex Facility Completes FDA Inspection

IA site GMP compliant, with no Form 483 observations

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex Corp. has successfully completed an FDA inspection of its API manufacturing facility in Charles City, IA. The inspection found the site to be compliant with GMP principles and guidelines, with no Form 483 observations issued. The FDA inspected the facility from July 31 to August 2, 2013.
 
Joe Nettleton, Cambrex’ vice president operations and Charles City site director, said, “We are very pleased with the results of this latest FDA inspection, which further strengthens our track record of outstanding regulatory compliance. We commit significant resources and work diligently to maintain high quality standards and continuously improve quality platforms within Cambrex.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics